629 related articles for article (PubMed ID: 12346920)
1. Injectable contraception: the USA perspective.
Kaunitz AM
IPPF Med Bull; 1992 Dec; 26(6):1-3. PubMed ID: 12346920
[TBL] [Abstract][Full Text] [Related]
2. Statement on injectable contraception.
International Planned Parenthood Federation IPPF
IPPF Med Bull; 1982 Dec; 16(6):3-4. PubMed ID: 12338511
[TBL] [Abstract][Full Text] [Related]
3. FDA gives final approval to Depo amid concerns over safety, cost and coercion.
Wash Memo Alan Guttmacher Inst; 1992 Nov; (17):2-3. PubMed ID: 12344620
[TBL] [Abstract][Full Text] [Related]
4. A comparison of levonorgestrel implants with depo-medroxyprogesterone acetate injections for contraception.
London RS
J SOGC; 1993 Oct; 15(8):925-8, 32. PubMed ID: 12318530
[TBL] [Abstract][Full Text] [Related]
5. Researcher explains status of Depo Provera. [Answer to question of Marienetta Blackwell].
Greenspan A
Contracept Technol Update; 1981 Mar; 2(3):35-6. PubMed ID: 12337540
[TBL] [Abstract][Full Text] [Related]
6. Millions of couples to have choice of injectable contraceptive.
Integration; 1996; (47):41. PubMed ID: 12347310
[TBL] [Abstract][Full Text] [Related]
7. Facts about injectable contraception.
Contracept Rep; 1994 Mar; 5(1):1-2. PubMed ID: 12287737
[TBL] [Abstract][Full Text] [Related]
8. Injectable contraceptives: safe and effective.
IPPF Med Bull; 1982 Feb; 16(1):3-4. PubMed ID: 12264296
[TBL] [Abstract][Full Text] [Related]
9. Depo Provera. Position paper on clinical use, effectiveness and side effects.
Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M
Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
[TBL] [Abstract][Full Text] [Related]
10. Depot medroxyprogesterone acetate contraception and the risk of breast and gynecologic cancer.
Kaunitz AM
J Reprod Med; 1996 May; 41(5 Suppl):419-27. PubMed ID: 8725705
[TBL] [Abstract][Full Text] [Related]
11. Long-term use of three-monthly injectable contraceptive DMPA not linked to breast cancer.
Entre Nous Cph Den; 1996 May; (32):11. PubMed ID: 12222270
[TBL] [Abstract][Full Text] [Related]
12. FDA board investigates Depo-Provera safety.
Contracept Technol Update; 1983 Mar; 4(3):25-7. PubMed ID: 12266161
[TBL] [Abstract][Full Text] [Related]
13. Progestin-only injectables offer many advantages.
Finger WR
Netw Res Triangle Park N C; 1995 Jun; 15(4):16-20. PubMed ID: 12289828
[TBL] [Abstract][Full Text] [Related]
14. New year, new option: Cyclo-Provera awaits word.
Contracept Technol Update; 1998 Jan; 19(1):3-4. PubMed ID: 12348212
[TBL] [Abstract][Full Text] [Related]
15. Researchers can now investigate long-term effects of OCs on cancer.
Rubin GL; Peterson HB
Contracept Technol Update; 1985 Jan; 6(1):7-12. PubMed ID: 12279918
[TBL] [Abstract][Full Text] [Related]
16. Injectable contraceptives.
Toppozada M
Contracept Deliv Syst; 1982 Apr; 3(2):161-70. PubMed ID: 12338171
[TBL] [Abstract][Full Text] [Related]
17. Acceptability study of the two versus three monthly injectable contraceptives.
Aly FA; El-genedi MM; Toppozada HK; El-abd M; Loutfi I
Dirasat Sukkaniyah; 1984; 11(69):27-39. PubMed ID: 12179796
[TBL] [Abstract][Full Text] [Related]
18. [Prolonged use of medroxyprogesterone acetate for contraception].
Pena Delgado J; Aleman Herrera M; Baez Reyes A
Sem Med Mex; 1981 Jun; 98(11):331-50. PubMed ID: 12279435
[TBL] [Abstract][Full Text] [Related]
19. The future for injectable contraceptives.
Rutter T
Afr Health; 1993 Mar; 15(3):18-9. PubMed ID: 12344840
[TBL] [Abstract][Full Text] [Related]
20. Depo-Provera highly effective as injectable contraceptive.
Denniston GC
Contracept Technol Update; 1985 Dec; 6(12):167-8. PubMed ID: 12280301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
